Investors

Latest Announcements

Press Release

Woke Announces First Shipment of Natural Health Products from HAVN Life Sciences

Read More
Press Release

Woke Enters Clinical Agreement with Macquarie University for WP001 Low-dose Psilocybin for Moderate Depression

Read More
Press Release

Woke Signs Manufacturing Agreement with IDT Australia for Novel Psilocybin Formulations to Treat Depression

Read More
Press Release

Woke Expands Partnership with Monash University to Develop Novel Psilocybin Formulation for Treatment- Resistant Depression

Read More

Latest Presentations

Latest Media

Media

Could psychedelic drugs be the key to treating mental health issues?

Read More
Media

Channel 9 News: Macquarie University trial of WP001 for moderate depression

Read More
Media

Macquarie University media release regarding clinical trial with Woke

Read More
Media

CY2022 CEO Corporate Overview

Read More

ACN: 651 290 729

Address: Suite 301, 10 Bridge St, Sydney NSW 2000 Australia

Email: info@wokeph.com